2Report of a WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. 1994 WHO technical Report Series No. 843, Geneva: WHO, 1994,121-129.
3NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and Therapy, Osteoporosis prevention, diagnosis, and therapy. JAMA, 2001.285:785-795.
7Nakayama H.Active vitamin D3 therapy for guiucocorticoidinduced osteoporosis[J].Ciin Caicium,2006,16(7):117.
8Hitz MF,Jensen JE,Eskiidsen PC.Bone minerai density and bone markers in patients with a recent low-energy fracture:effect of 1 y of treatment with caicium and vitamin D[J].Am J Ciin Nutr,2007,986(1):251-259.
9Dennis M,Black.Fracture risk reduction with alendronate in women with osteoporoois:The fracture invention trial[J].The Journal of Clinical Endocrinology and Met Rbo lism,2000,11:4118-4124.